Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Egypt
|
| gptkbp:exportedTo |
over 50 countries
|
| gptkbp:founded |
1983
|
| gptkbp:founder |
Dr. Hassan Abbas Helmy
|
| gptkbp:headquarters_location |
gptkb:Alexandria,_Egypt
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharco Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
gptkb:Africa
gptkb:Asia gptkb:Europe gptkb:Middle_East |
| gptkbp:notable_for |
large-scale hepatitis C treatment programs
|
| gptkbp:numberOfEmployees |
over 8,000
|
| gptkbp:products |
generic drugs
over-the-counter medicines branded drugs |
| gptkbp:subsidiary |
Pharco B International
Pharco Impex Pharco Laboratories Pharco Pharmaceuticals International |
| gptkbp:website |
https://www.pharco.org/
|
| gptkbp:bfsParent |
gptkb:Pharco_FC
gptkb:ravidasvir/sofosbuvir |
| gptkbp:bfsLayer |
8
|